Veracyte, Inc. Files 2024 10-K Report
Ticker: VCYT · Form: 10-K · Filed: Feb 28, 2025 · CIK: 1384101
| Field | Detail |
|---|---|
| Company | Veracyte, Inc. (VCYT) |
| Form Type | 10-K |
| Filed Date | Feb 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, healthcare
Related Tickers: VCYT
TL;DR
VERACYTE (VCYT) filed its 2024 10-K. Full financials and biz details out now.
AI Summary
Veracyte, Inc. filed its 2024 10-K report on February 28, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, headquartered in South San Francisco, CA, operates in the medical laboratories sector. The filing covers its business operations, financial statements, and risk factors for the period.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Veracyte's financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a publicly traded company in the healthcare sector, Veracyte faces inherent risks related to regulatory changes, market competition, and product development, which are detailed in its 10-K filing.
Key Numbers
- 2024 — Fiscal Year (The primary year covered by the 10-K filing.)
- 1231 — Fiscal Year End (Indicates the end date of the fiscal year reported.)
- 20250228 — Filing Date (The date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- VERACYTE, INC. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end for the reported period
- 2025-02-28 (date) — Filing date of the 10-K report
- SOUTH SAN FRANCISCO, CA (location) — Company headquarters location
- 8071 (industry_code) — Standard Industrial Classification for Medical Laboratories
FAQ
What is Veracyte, Inc.'s primary business sector?
Veracyte, Inc. operates in the SERVICES-MEDICAL LABORATORIES sector, with a Standard Industrial Classification code of 8071.
When did Veracyte, Inc. file its 2024 10-K report?
Veracyte, Inc. filed its 2024 10-K report on February 28, 2025.
What is the fiscal year end for the period covered by this 10-K?
The conformed period of report for this 10-K is December 31, 2024.
Where is Veracyte, Inc. headquartered?
Veracyte, Inc. is headquartered at 6000 Shoreline Court, Suite 300, South San Francisco, CA 94080.
What was Veracyte, Inc.'s former company name?
Veracyte, Inc.'s former company name was CALDEROME INC, with a date of name change on December 19, 2006.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 28, 2025 regarding VERACYTE, INC. (VCYT).